Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1747-1753

  Sorbi, D ^a   French, D L ^b   Nuovo, G J ^b   Kew, R R ^b   Arbeit, L A ^a   Gruber, B L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE;

ANTIGENICITY; ARTICLE; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FIBROBLAST; GIANT CELL ARTERITIS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSCRIPTION; TEMPORAL ARTERY;

EID: 0029783511     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391019     Document Type: Article

References (52)

1. Hunder GG, Lie JT, Goronzy JJ, Weyand CM: Pathogenesis of giant cell arteritis. Arthritis Rheum 36:757-761, 1993
2. Rousseau P: Giant cell arteritis. Arch Fam Med 3:628-632, 1994
3. Jennings GH: Arteritis of temporal arteries. Lancet 1:424-428, 1938
4. Lie JT, Brown AL Jr, Carter ET: Spectrum of aging changes in temporal arteries: its significance in interpretation of biopsy temporal arteritis. Arch Pathol Lab Med 90:278-285, 1970
5. Hunder GG, Michet CJ: Giant cell arteritis and polymyalgia rheumatica. Rheum Dis Clin North Am 11:471-483, 1985
6. Lie JT, and Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis: Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 33:1074-1087, 1990
7. Huston KA, Hunder GG: Giant cell (cranial) arteritis: a clinical review. Am Heart J 100:99-107, 1980
8. Gonzales EB, Miller SB: Polymyalgia rheumatica and giant cell arteritis: making the diagnosis. J Musculoskeletal Med 9:117-124, 1992
9. Healey LA: Polymyalgia rheumatica and giant cell arteritis. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea and Febiger, 1993
10. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128, 1990
11. Parker F, Healey LA, Wilske KR, Odland G: Light and electron microscopic studies on human temporal arteritis with special reference to alterations related to senescence, atherosclerosis, and giant cell arteritis. Am J Pathol 79:57-80, 1975
12. O'Brien JP, Regan W: Are we losing focus on the internal elastic lamina in giant cell arteritis? Arthritis Rheum 35:794-798, 1992
13. Kimmelstiel P, Gilmour MT, Hodges HH: Degeneration of elastic fibers in granulomatous giant cell arteritis (temporal arteritis). Arch Pathol 54:157-168, 1952
14. Senior RM. Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-7875, 1991
15. Okada Y, Katsuda S, Okada Y, Nakanishi I: An elastinolytic enzyme in the culture medium of human arterial smooth muscle cells. Cell Biol Int 17:863-869, 1993
16. Bieth JG: Biology of Extracellular Matrix: Regulation of Matrix Accumulation. Orlando, FL, Academic Press, 1986
17. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR: Proteinase 3: a distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 82:1963-1973, 1988
18. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 267:21712-21719, 1992
19. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanashi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: purification and activation of the precursor and enzyme properties. Eur J Biochem 194:721-723, 1990
20. Welgus HG, Fliszar CJ, Seltzer JL, Schmid TM, Jeffrey JJ: Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72 kDa type IV collagenase. J Biol Chem 265:13521-13527, 1990
21. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV 40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221, 1989
22. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kroneberger AHC, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587, 1988
23. Huhtala P, Chow LT, Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 265:11077-11082, 1990
24. Sorbi D, Fadly M, Hicks R, Alexander S, Arbeit L: Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int 44:1266-1272, 1993
25. Hibbs MS, Hoidal JR, Kang AH: Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 80:1644-1650, 1987
26. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI: Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J Clin Invest 86:1496-1502, 1990
27. Tetlow LC, Lees M, Nagase H, Woolley DE: Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 13:53-59, 1993
28. Unemori EN, Hibbs EP, Amento P: Constitutive expression of a 92 kDa gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656-1662, 1991
29. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545, 1994
30. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12:168-184, 1992
31. Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL: Correlation of the in situ detection of the polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55:267-275, 1995
32. Wilkinson MJ, Cohen RL, Shuman MA: A nonradioactive assay for type IV collagen degradation. Anal Biochem 185:294-296, 1990
33. Ramos-DeSimone N, Moll UM, Quigley JP, French DL: Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma 12:349-363, 1993
34. Ramos-DeSimone N, French DL: Monoclonal antibodies to human MMP-9. Ann New York Acad Sci 732:469-471, 1994
35. Moll UM, Youngleib GL, Rosinski KB, Quigley JP: Tumor promoter-stimulated M, 92,000 gelatinase secreted by normal and malignant human cells - isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50:6162-6170, 1990
36. Nuovo GJ: PCR In Situ Hybridization: Protocols and Applications. Second edition. New York, Raven Press, 1994
37. Nuovo GJ, Gallery F, MacConnell P, Braun A: In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor a in the central nervous system. Am J Pathol 144:659-666, 1994
38. Henson PM, Zanolari B, Schwartzmann NA, Hong SR: Intracellular control of human neutrophil secretion: C5a-induced stimulus specific desensitization and the effects of cytochalasin B. J Immunol 121:851-855, 1978
39. Banks PM, Cohen MD, Ginsburg WW, Hunder GG: Immunohistologic and cytochemical studies of temporal arteritis. Arthritis Rheum 26:1201-1207, 1983
40. Kalebic T, Garbisa S, Glaser B, Liotta LA: Basement membrane collagen degradation by migrating endothelial cells. Science 221: 281-283, 1983
41. Schnaper HW, Grant DS, Stetler-Stevenson WG: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156:235-246, 1993
42. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA: Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162:499-510, 1994
43. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM: Identification of 92 kDa gelatinase in human coronary atherosclerotic lesions. Circulation 91:2125-2131, 1995
44. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, Tilson MD: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20:814-820, 1994
45. O'Brien JP: A concept of diffuse actinic arteritis: the role of actinic damage to elastin in "age change" and arteritis of the temporal artery and in polymyalgia rheumatica. Br J Dermatol 98:1-13, 1978
46. Klominek J, Robert KH, Sundqvist KG: Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance. Cancer Res 53:4376-4382, 1993
47. Malone JD, Richards M, Jeffrey JJ: Recruitment of peripheral mononuclear cells by mammalian collagenase digests of type I collagen. Matrix 11:289-295, 1991
48. Rosen EM, Goldberg ID: Protein factors which regulate cell motility. In Vitro Cell Dev Biol 25:1079-1087, 1989
49. Calamia KT, Moore SB, Elvebach LR, Hunder GG: HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 8:993-996, 1981
50. Richardson JE, Gladman DD, Fam A, Keystone EC: HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 30:1293-1297, 1987
51. Weyand CM, Goronzy JJ: Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 7:30-36, 1995
52. Wernick R, Davey M, Bonafede P: Familial giant cell arteritis: report of a HLA-typed sibling pair and a review of the literature. Clin Exp Rheumatol 12:63-66, 1994